FDA Investigator Santiago Gallardo Johnson

Santiago Gallardo Johnson has conducted inspections on 54 sites in 4 countries as of 24 Apr 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
54
Last Inspection Date:
24 Apr 2023
Investigator Role:
FDA Investigator
Redica ID:
100005290
Countries of Inspections:
United States of America, Japan, Australia, Germany
FDA Investigators that have inspected at least one site in common with Santiago Gallardo Johnson:
Adam R Cooke, Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Albert C Cheng, Alexandra B Pitkin, Allison A Rodriguez, Amanda L Fyles, Amir Alavi, Andrew Le, Andrew S Limson, Anita Narula, PhD, Anney Lin, Anthony A Charity, Arsen Karapetyan, Ashley N Queen, PhD, Azza Talaat, Babajide Michael Osunsanmi, Bichsa T Tran, Binh T Nguyen, Brien C Fox, Bruce H Mccullough, Bryan A Galvez, Calvin B Koerner, Carla J Lundi, Carolina D Vasquez, Caroline H Le, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, Cecilia H Kieu, Chani Broner, PhD, Chelsea N Sealey, Cheryl A Clausen, Christina Capacci Daniel, PhD, Christopher M Hernandez, Christopher M Jenner, Christopher M Reed, Christopher R Czajka, Christopher S Keating, Claudia Mperez Kasmarski, Comyar Shoghi, Courtney R Bratina, Crystal Monroy, Cynthia Jim, CSO, Daniel J Lahar, Darla J Christopher, Darren S Brown, Darrin E Davis, David G Whitman, Deborah A Greco, Debra I Love, Dennis Cantellops Paite, Devon Jenkins, Diana M Rand, Diane Cvan Leeuwen, Djamila Harouaka, Donna Mwilliams Hill, PhD, Dr. Chunchang Fang, Dr. Zhihao Qiu (Peter), PhD, Dyana K Stone, Eileen A Liu, Elizabeth D Gonzales, Emilie E Kahn, Erika V Butler, Esteban Beltran, Esther B Gamallo Herrera, Esther C Broner, PhD, Finn A Slizza, Francis A Guidry, Frederick L Fricke, Gabriel M Guevarra, Gam S Zamil, Gene D Arcy, Geraldine H Matining, Geraldine M Peregrin, Gerard T Schneider, Ginger M Sykes, Glen C Lawrence, Grace Deneke, Grace E Mcnally, Grace P Santos, Gregory A Berg, Gunneet Kaur, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Heidy C Perales, Helen B Ricalde, Homero W Aguilar, Isabel Y Espinosa, Jacqueline Mdiaz Albertini, Jai P Singh, James B Arnett, James L Dunnie, Jr, James M Timper Jr, James R Montero, Jamie L Dion, Janet D Blount, Jasmine N Thompson, Jazmine M Welcher, Jeffery A Johnson, Jeffrey P Raimondi, Jennifer M Gogley, Jeremy Beber, Jeremy H Nguyen, Jessie E Morris, Joan A Loreng, Joe X Phillips, Joey V Quitania, John A Gonzalez, John P Jorgensen, Jolanna A Norton, Jonathan R Campos, Joseph X Phillips, Juan A Morales, Karen A Wolnik, Karen G Hirshfield, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathy Chiu, Kathy Kuo, Kelley, Kelvin Cheung, Kelvin X Sanders, Kenneth H Williams, Kham Phommachanh, Kim Lthomas Cruse, Kimberley A Hoefen, Kumar G Janoria, Lata C Mathew, PhD, Laurimer Kuilan Torres, LCDR Chad N Thompson, Lestine C Webb, Lewis K Antwi, Lilly O Barton, Linda F Murphy, Linda M Cheny, Linda Thai, Lisa Shin, Lixia Cai, LT Richard A Lyght, Lucas B Leake, Luis Mburgos Medero, Marc A Jackson, Jr, Marco S Esteves, Marcus F Yambot, Margaret M Annes, Marianela Aponte Cruz, Marie B Buen Bigornia, Marie T Falcone, Marijo B Kambere, PhD, Marion W Nadeau, Mariza M Jafary, Mark A Tucker, Marlene G Swider, Marlo Ianm Alintanahin, Mary Ewilkerson Brinsko, Mary Jeanet Mcgarry, Matthew B Casale, Matthew J Johnson, Matthew R Clabeaux, Matthew R Dionne, Michael A Charles, Michael D Garcia, Michael E Maselli, Michael J Kuchta, Michael R Goga, Michael S Araneta, Michael Shanks, MS, Michael T Cyrus, Mihaly S Ligmond, Minh D Phan, Nancy G Schmidt, Nayan J Patel, Nicholas A Violand, Nicholas L Hunt, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Cortez, Patricia D Stahnke, Patricia F Alberico, Paul A Bonneau, Phillip L Toy, Prabhu P Raju, Rachel C Stanton, Raymond T Oji, Rebecca K Olin, Richmond K Yip, Ricki A Chase, Robert D Tollefsen, Robert J Martin, Roger F Zabinski, Roger L Farmer, Rose Xu, Rowena S Nguyen, Rumany C Penn, PharmD, Ryan J Borges, Saied A Asbagh, Samantha J Bradley, Samina S Khan, Sangeeta M Khurana, PhD, Santos E Camara, Scott K Zika, Scott N Lim, Sean P Desbrow, Selene T Torres, Seneca D Toms, Shannon B Ruelle, Shelley H Beausoleil, Sidney B Priesmeyer, Simone E Pitts, Sonya L Karsik, RAC, Sparky L Bartee, Stephanie A Slater, MS, Steve Y Rhieu, PhD, Steven C Madzo, Sundy V Sedwick, Susan M Jackson, Susan T Hadman, Taichun Qin, PhD, Tajah L Blackburn, Tamala P Bogan, Tamala P Magee, Tamara L Setzer, Tara L Breckenridge, Tara L Greene, Ted L Anderson, Terrance P Nguyen, Terri L Dodds, Thanh M Andrews, Thao T Kwan, Theresa Kirkham (NMI), Theressa B Smith, Thomas J Arista, Thomas R Beilke, Thuy T Nguyen, LCDR, Timothy T Kapsala, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vanessa R Muller, Vashti E Bocker, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Walden H Lee, Wayne W Grundstrom, Wenzheng Wendy Zhang, Xiaohui Shen, Yasamin Ameri, Yi Wang, PhD, Yumi J Hiramine, Yvette E Guillermo, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zhong Li, PhD

Santiago Gallardo Johnson's Documents

Publish Date Document Type Title
August, 2019 FDA 483 Response Polypeptide Laboratories, Inc. - Form 483R, 2019-09-13
December, 2019 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2019-12-20
March, 2022 FDA 483 Nanoimaging Services, Inc. - Form 483, 2022-03-03
November, 2022 FDA 483 Hyland's Consumer Health Inc. - Form 483, 2022-11-29
August, 2019 FDA 483 Polypeptide Laboratories, Inc. - Form 483, 2019-08-30
March, 2018 EIR Pacira Pharmaceuticals, Inc. - EIR, 2018-03-01
August, 2018 FDA 483 Fill it Pack It Inc - Form 483, 2018-08-08
January, 2023 FDA 483 Societal CDMO San Diego, LLC - Form 483, 2023-01-25
February, 2018 FDA 483 Response Samson Pharmaceuticals, Inc. - Form 483R, 2018-02-20
May, 2018 FDA 483 220 Laboratories LLC. - Form 483, 2018-05-17
September, 2022 FDA 483 Daito Pharmaceutical Co., Ltd - Form 483, 2022-09-16
October, 2019 FDA 483 Mayne Pharma International Pty Ltd. - Form 483, 2019-10-18
April, 2021 EIR Societal CDMO San Diego, LLC - EIR, 2021-04-07
August, 2021 FDA 483 Response Teva Parenteral Medicines, Inc. - Form 483R, 2021-09-13
October, 2019 FDA 483 Botanical Resources Australia-Manufacturing Services Pty Ltd - Form 483, 2019-10-11
January, 2020 FDA 483 Samson Pharmaceuticals, Inc. - Form 483, 2020-01-29
September, 2022 FDA 483 Meiji Seika Pharma Co., Ltd. - Form 483, 2022-09-02
July, 2022 FDA 483 U.S. Continental Marketing, Inc. - Form 483, 2022-07-21
August, 2021 FDA 483 Teva Parenteral Medicines, Inc. - Form 483, 2021-08-20
May, 2021 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2021-05-25
April, 2019 FDA 483 Diamond Wipes International, Inc. - Form 483, 2019-04-19
September, 2019 EIR Nitto Avecia Pharma Services, Inc. - EIR, 2019-09-20
December, 2019 FDA 483 Response Ajinomoto Althea, Inc. - Form 483R, 2019-12-20
December, 2019 EIR Ajinomoto Althea, Inc. - EIR, 2019-12-20
April, 2021 FDA 483 Societal CDMO San Diego, LLC - Form 483, 2021-04-07
March, 2018 FDA 483 Pacira Pharmaceuticals, Inc. - Form 483, 2018-03-01
December, 2017 FDA 483 TOLMAR, INC - Form 483, 2017-12-06
August, 2019 EIR Ajinomoto Althea, Inc. - EIR, 2019-08-07
August, 2019 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2019-08-07
October, 2021 FDA 483 Expert Chemical Analysis, Inc. - Form 483, 2021-10-07
February, 2019 EIR Bachem Americas, Inc. - EIR, 2019-02-05
December, 2017 FDA 483 Response TOLMAR, INC - Form 483R, 2018-01-03
December, 2021 FDA 483 Genlabs Corporation - Form 483, 2021-12-09
January, 2018 EIR ACTA Laboratories Inc - EIR, 2018-01-19
August, 2019 EIR Polypeptide Laboratories, Inc. - EIR, 2019-08-30
March, 2018 EIR Nelson Laboratories, LLC - EIR, 2018-03-30
January, 2018 FDA 483 ACTA Laboratories Inc - Form 483, 2018-01-19
October, 2021 FDA 483 TG Labs, Inc. - Form 483, 2021-10-29
February, 2018 FDA 483 Samson Pharmaceuticals, Inc. - Form 483, 2018-02-09
October, 2017 FDA 483 University Rx Specialist, dba University Compounding Pharmacy - Form 483, 2017-10-27
October, 2018 FDA 483 San Diego Compounding Pharmacy - Form 483, 2018-10-25
December, 2017 EIR TOLMAR, INC - EIR, 2017-12-06
August, 2019 FDA 483 Southern California Compounding Pharmacy, LLC - Form 483, 2019-08-01
April, 2021 FDA 483 Response Societal CDMO San Diego, LLC - Form 483R, 2021-04-28
July, 2017 FDA 483 Polypeptide Laboratories, Inc. - Form 483, 2017-07-19
April, 2019 EIR Sterigenics Radiation Technologies, LLC - EIR, 2019-04-26
September, 2022 FDA 483 Ishihara Sangyo Kaisha, Ltd. - Form 483, 2022-09-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more